Pseudo-outbreak of methicillin-resistant Staphylococcus aureus

P T Ender1, S J Durning, W K Woelk

  • 1Division of Infectious Diseases, Wright-Patterson Medical Center, Wright-Patterson AFB, Ohio 45433-5529, USA.

Mayo Clinic Proceedings
|September 17, 1999
PubMed
Abstract

Insights

Laboratory misclassification led to a high rate of methicillin-resistant Staphylococcus aureus (MRSA) detection. Most MRSA cases were false positives, causing unnecessary vancomycin use and infection control measures.

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Diagnostic Accuracy

Background:

  • High rates of methicillin-resistant Staphylococcus aureus (MRSA) can strain healthcare resources.
  • Accurate laboratory identification of MRSA is crucial for effective treatment and infection control.

Purpose of the Study:

  • To investigate if laboratory misclassification contributed to the observed high rate of MRSA.
  • To assess the impact of potential misclassification on patient care and hospital protocols.

Main Methods:

  • Comparison of automated Vitek system results with oxacillin agar screen and broth microdilution.
  • Testing of discordant isolates for the presence of the mecA gene.
  • Evaluation of S. aureus isolates over a 60-day period.

Main Results:

  • 72% of isolates initially identified as MRSA by the Vitek system were oxacillin susceptible via agar screening.
  • Discordant isolates were confirmed as oxacillin susceptible and mecA gene negative.
  • Misclassification led to unnecessary vancomycin use and infection control measures.

Conclusions:

  • Automated susceptibility testing for S. aureus requires periodic validation.
  • Hospitals should implement confirmatory testing to prevent MRSA misclassification.
  • Accurate MRSA identification is vital to avoid resource misallocation.

Related Concept Videos

Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...